Sca-1 is an early-response target of histone deacetylase inhibitors and marks hematopoietic cells with enhanced function

Walasek MA, Bystrykh LV, Olthof S, de Haan G, van Os R Exp. Hematol. 2013 Jan;41(1):113-23.e2 PMID: 22989761 Abstract Histone deacetylase inhibitors (HDIs) have been shown to enhance hematopoietic stem and progenitor cell activity and improve stem cell outcomes after